Toward a hierarchy of mechanisms in CaMKII-mediated arrhythmia

Kevin P Vincent1, Andrew D McCulloch2, Andrew G Edwards3

  • 1Department of Bioengineering, University of California San Diego La Jolla, CA, USA.

Insights

Calcium/calmodulin-dependent protein kinase II (CaMKII) contributes to cardiac arrhythmia across diverse heart conditions. This review explores whether CaMKII acts as a common driver or utilizes distinct mechanisms in various cardiac pathologies.

Area of Science:

  • Cardiology
  • Molecular Biology
  • Biochemistry

Background:

  • Calcium/calmodulin-dependent protein kinase II (CaMKII) is implicated in arrhythmogenesis across various cardiac pathologies.
  • These pathologies include structural remodeling, electrophysiologic changes, and channelopathies.
  • The broad involvement of CaMKII suggests a central role in heart rhythm disturbances.

Purpose of the Study:

  • To investigate the mechanistic role of CaMKII in cardiac arrhythmia.
  • To determine if CaMKII acts as a common arrhythmogenic factor or employs diverse mechanisms depending on the cardiac pathology.
  • To review evidence on how CaMKII's molecular actions promote arrhythmia in different pathophysiologic contexts.

Main Methods:

  • Literature review of mechanistic evidence on CaMKII and cardiac arrhythmia.
  • Analysis of studies examining CaMKII activity in diverse cardiac conditions.
  • Dissection of molecular pathways linking CaMKII to arrhythmogenesis.

Main Results:

  • CaMKII activity is a common feature in a wide spectrum of cardiac arrhythmias.
  • Evidence supports both a common CaMKII-dependent mechanism and pathology-specific pathways.
  • CaMKII's diverse molecular actions contribute to arrhythmia in different disease contexts.

Conclusions:

  • CaMKII plays a significant role in promoting cardiac arrhythmia.
  • Understanding CaMKII's multifaceted mechanisms is crucial for developing targeted antiarrhythmic therapies.
  • Further research is needed to elucidate the specific roles of CaMKII in various cardiac diseases.

Related Concept Videos

Mechanism of Cardiac Arrhythmias01:28

Mechanism of Cardiac Arrhythmias

Arrhythmias are irregular heart rhythms occurring when the heart's electrical impulses become abnormal. These disturbances can lead to various symptoms, depending on their severity and the underlying cause. Some common factors contributing to arrhythmias include hypoxia, ischemia, electrolyte imbalances, excessive catecholamine exposure, drug toxicity, and muscle overstretching. Arrhythmias can be classified into two main types based on the rate and site of origin of abnormal heart rhythms.
2.7K
Disturbances in Heart Rhythm01:29

Disturbances in Heart Rhythm

Arrhythmia or dysrhythmia refers to an abnormal heart rhythm caused by a defect in the heart's conduction system. It can cause the heart to beat irregularly, too quickly, or too slowly, leading to symptoms like chest pain, shortness of breath, and fainting. Factors such as stress, caffeine, alcohol, nicotine, cocaine, certain drugs, congenital defects, diseases, and electrolyte abnormalities can trigger arrhythmias.
Arrhythmias are categorized by their speed, rhythm, and origin. A slow heart...
5.3K
Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers01:12

Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers

Class III antiarrhythmic drugs are a group of medications that can prolong action potentials in the heart. They achieve this by blocking potassium channels or enhancing inward currents from sodium channels. However, these drugs have a unique property of "reverse use-dependence," which is most pronounced at slower heart rates and can lead to torsades de pointes—a specific type of arrhythmia. However, it is essential to note that excessive QT interval prolongation—a measure of...
2.9K
Antiarrhythmic Drugs: Class II Agents as β-Adrenergic Blockers01:24

Antiarrhythmic Drugs: Class II Agents as β-Adrenergic Blockers

Adrenergic stimulation generally impacts cardiac rate and rhythm. Specifically, stimulation of the β-adrenoceptors triggers an increase in intracellular calcium ion influx and pacemaker currents, which may cause arrhythmias. Catecholamines like adrenaline also demonstrate β2-adrenoceptor-mediated hypokalemia, impacting cardiac action potential and disrupting the normal cardiac rhythm. Class II antiarrhythmic drugs are β-adrenoceptor antagonists or β-blockers, which...
2.3K
ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias01:25

ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias

Arrhythmia is a condition characterized by an irregular heart rhythm, with ECG changes that differ based on its origin and nature. The types of arrhythmias discussed below include atrial, junctional, and ventricular arrhythmias.Atrial ArrhythmiasPremature Atrial Complexes (PACs): PACs are early atrial beats caused by stress, caffeine, alcohol, electrolyte imbalances, hypoxia, hyperthyroidism, or certain medications (e.g., bronchodilators and decongestants). The ECG shows early P waves with an...
1.1K
G-Protein Gated Ion Channels01:21

G-Protein Gated Ion Channels

GPCRs are primarily responsible for our sense of smell, taste, and vision.  The binding of a sensory stimulus activates GPCR to stimulate effector proteins, many of which are ion channels in the sensory organs. GPCRs modulate the opening and closing of the target ion channels either directly by binding them, or by releasing second messengers that activate these channels. As ions move across the membrane, the membrane potential is altered, which induces an appropriate response.
Sensory...
5.4K